Plan-Class Specific Reference Quality Assurance for Volumetric Modulated Arc Therapy

Article information

J Radiat Prot Res. 2019;44(1):32-42
Publication date (electronic) : 2019 March 31
doi : https://doi.org/10.14407/jrpr.2019.44.1.32
1Department of Nuclear Engineering, Hanyang University, Seoul, Korea
2Department of Radiation Oncology, Hanyang University Medical Center, Hanyang University, Seoul, Korea
Corresponding author: Seonghoon Kim, Department of Radiation Oncology, Hanyang University Medical Center, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea, Tel: +82-2-2290-8625, Fax: +82-2-2290-8630, E-mail: dochokim@gmail.com
Received 2019 February 20; Accepted 2019 February 26.

Abstract

Background

There have been much efforts to develop the proper and realistic machine Quality Assurance (QA) reflecting on real Volumetric Modulated Arc Therapy (VMAT) plan. In this work we propose and test a special VMAT plan of plan-class specific (pcsr) QA, as a machine QA so that it might be a good solution to supplement weak point of present machine QA to make it more realistic for VMAT treatment.

Materials and Methods

We divided human body into 5 treatment sites: brain, head and neck, chest, abdomen, and pelvis. One plan for each treatment site was selected from real VMAT cases and contours were mapped into the computational human phantom where the same plan as real VMAT plan was created and called plan-class specific reference (pcsr) QA plan. We delivered this pcsr QA plan on a daily basis over the full research period and tracked how much MLC movement and dosimetric error occurred in regular delivery. Several real patients under treatments were also tracked to test the usefulness of pcsr QA through comparisons between them. We used dynalog file viewer (DFV) and Dynalog file to analyze position and speed of individual MLC leaf. The gamma pass rate from portal dosimetry for different gamma criteria was analyzed to evaluate analyze dosimetric accuracy.

Results and Discussion

The maxRMS of MLC position error for all plans were all within the tolerance limit of <0.35 cm and the positional variation of maxPEs for both pcsr and real plans were observed very stable over the research session. Daily variations of maxRMS of MLC speed error and gamma pass rate for real VMAT plans were observed very comparable to those in their pcsr plans in good acceptable fluctuation.

Conclusion

We believe that the newly proposed pcsr QA would be useful and helpful to predict the mid-term quality of real VMAT treatment delivery.

Introduction

Quality Assurance (QA) in radiotherapy is generally practiced for the two main parts; to test the performance of medical LINAC machine and to verify the delivering accuracy of patient treatment plan. The former focuses on the mechanical performance and radiation accuracy of the machine and is performed on a regular period basis like daily, monthly, and yearly by recommendations or national regulations. The latter aims for a patient treatment using Intensity Modulation Radiotherapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) and is usually carried out before first start of treatment. Task Group 142 Report by American Association of Physicists in Medicine (AAPM) [1], one of the latest recommendations on QA of medical accelerators, mentions machine QA for IMRT but focuses only on mechanical test of MLC without any detailed mention of IMRT plan QA itself.

VMAT, the state-of-the-art beam delivering technique in a radiation therapy is much more advanced radiotherapy than traditional IMRT and is now commonly practiced in clinical situation. The complex features of its beam delivering system demands stricter QA than that for conventional fixed gantry IMRT. In modern radiotherapy, all clinical institutes do their best to get the optimal VMAT QA to guarantee successful dose delivering to tumor and normal tissue as expected in treatment planning system. However, there are no special mentions of regular machine QA for VMAT in TG142 report [1] released in 2009 and Korean regulation [2] in 2015 mostly based on TG142.

What is the best QA for IMRT or VMAT plan? The ideal plan QA is in principle to be performed in three-dimensional patient body in real time while patient is under treatment for a full period of treatment. However, it is unrealistic and furthermore, there are no commercial tools available for such QA. The suboptimal QA as an alternative is to utilize patient-like phantom and carry out QAs on a daily base each time before daily treatment (we call it “full QA” for convenience in this work). The two-dimensional (2D) detector array systems like portal dosimetry and MatriXX (IBA Dosimetry GmbH, Schwarzenbruck, Germany) has a limitation to give three-dimensional information of dose distribution because patient CT image are not used, but are broadly practiced in clinical situation as a realistic QA tools. The three-dimensional QA systems like COMPASS (IBA Dosimetry GmbH) are commercially available but are improper to be used for daily based patient QA. Even though these two or three-dimensional QA systems are available in clinical practice, they are all for patient-specific plan QA and will give a great deal of workload for daily based QA. Considering realistic difficulties in clinical situation, the QA for patient plan is commonly carried out one time before start of first treatment (we call it “one QA” for convenience). One QA has good advantage as a realistic solution but cannot guarantee the full delivering accuracy over a full session of treatment. In other words, it cannot predict unexpected delivering errors occurring in not first day but another day of treatments. It necessitates another solution to make up for the deficiency of one QA.

There have been much efforts to develop the proper machine QA related to IMRT and VMAT [14]. AAPM TG119 [5] released in 2009 suggested various target structures in a simple box-shaped phantom, but they were for IMRT plan not for VMAT plan. Report 24 of Netherlands Commission on Radiation Dosimetry Subcommittee (NCS) released in 2015 developed significant guidelines for quality assurances and control for VMAT treatments and suggested a tumor site specific class solution as the machine QA for VMAT [4]. They gave general, but not detailed, guidelines for the development of VMAT plan by class solutions. Mohammad et al. introduced and tested the regular machine QA for VMAT where it was called representative VMAT QA [6], but it was simple and consisted of one Planning Target Volume (PTV) and a few organs at risk in a cubic water phantom.

We aim to perform and test a special VMAT plan proposed in this research as a machine QA so that it might be a good solution to supplement weak point of one QA to make it more realistic. In this work, we tried to develop the exclusive VMAT plan as regular machine QA simulating alike real VMAT plan. The computational human phantom developed by Choi et al. [7] was used to simulate a real humanlike body. The body was divided simply into five anatomical sections and VMAT plans representing each section were created from real VMAT plans. We named the plan a plan-class specific reference quality assurance (pcsr QA) in this research. Five pcsr QA plans were performed and tested in this work.

Materials and Methods

1. Plan classification

The aim of this study was to develop pcsr QA for VMAT. In accordance with this purpose, it is ideal that all the possible VMAT plans be classified and grouped together into each specific class with similar plan properties and that the pcsr QA, a reference QA representing each class, should be designed and planned. The plan class should be defined in principle by plan properties with different modulation level. It means that plans from totally different treatment sites like brain parts and pelvis parts are likely to belong to the same class. On the contrary, even plans in the same treatment sites each might go to different plan classes, that is to say, different modulation levels. We thought that the plan properties-based plan classification seems good theoretically, but we didn’t try it here because it looked not easy to first define plan properties and then classify plans by them. Instead of classifying plans by plan properties, which will be done later in follow-up study, in this research, we took a simple approach to classify plans by treatment sites (Figure 1). We took a simple assumption that plans in the same treatment site had similar plan properties.

Fig. 1

Classification of plans by treatment sites. The whole body is divided into five anatomical divisions and the plan-class specific QA plans for each section are created.

We divided the whole body into five treatment sites (Figure 1) for convenience, brain, head and neck, chest, abdomen, and pelvis. One plan in each treatment sites was selected from real patient treatment cases and used to create the plan-class specific QA plan, named pcsr QA, respectively. In other words, the pcsr QA plan used real patient plan and therefore can be said to take much more advanced form of QA for VMAT than simple Picket Fence test (PF test) and IMRT QA in TG142 [1]. For this study VMAT cases with multiple fractions were selected and Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT) cases were excluded.

2. Creating pcsr QA plan

In this study, we aim to develop the QA plan modeling same as real patient treatment plan. In order to realize this, we need first the CT image set equivalent to real patient anatomy. Real patient CT images are the best candidate, but you are not supposed to use it for a research without getting permission from the hospital related Institutional Review Board. The QA, developed in this research is not for patient treatment but only for regular machine QA for VMAT plan. Therefore, for this QA we have no call to have the CT image exactly same as real human anatomy. If an artificial human CT imitating human body as close to real human body as possible was available, it could be a good alternative for real patient CT image. We used High-Definition Reference Korean-Man (HDRK-Man), the computational human phantom developed in Hanyang University Radiation Engineering Laboratory (HUREL) (Figure 2) to create human body like CT image. This phantom is the Polygon-Surface Reference Korean-Man [8] by converting the Visible Korean Human-Man voxel phantom [7] and adjusting the CT data to that of reference Korean data for height (171 cm), weight (68 kg), and 30 organs and tissue sizes. This phantom was used as VMAT QA-dedicated CT Image and will be called pcsr phantom here for convenience. If you visit the website http://hurel.hanyang.ac.kr, you can get more information on this phantom.

Fig. 2

The computational human phantom developed in Hanyang University Radiation Engineering Laboratory (HUREL) with name of HDRK-Man. It includes 30 organs. For more information visit http://hurel.hanyang.ac.kr.

In this study, the pcsr QA plan imitates a real VMAT patient plan. After selecting a real patient plan to be used as a model of a pcsr plan, contours in the real plan were mapped into the pcsr phantom (Figure 3). We fulfilled this job with the help of MIRADA (version 1.1.1), which is a software tool for Deformable Image Registration. Patient CT and Phantom CT are first fused in MIRADA and then organs at risk in patient CT are deformed and contoured in phantom CT. However, the contours made this way look somewhat different from original ones in size and shape and we trimmed and smoothed them a little bit manually so that they have the size and shape as similar to original one as possible.

Fig. 3

Mapping of contours in real patient CT into a pcsr phantom. (A) In the picture shows a real patient CT image and its contours of organs at risk and (B) shows phantom CT image and mapped contours. Mapped contours were so trimmed through manual smoothing that they imitate as close to original ones as possible.

We designed five pcsr QA plans from selected patient plans for each treatment site - brain, head neck, chest, abdomen, and pelvis- in our treatment planning systems (Eclipse, Varian Medical Systems, CA, USA) (Figure 4). The corresponding verification plans for them then were created and verified with portal dosimetry system. Here, we simply call them “pcsr verification plans”. The pcsr QA plans were made with the same plan conditions as selected real patient plans including same constraints imposed to PTV and organs at risk. We summarized them in Table 1, where we don’t show the constraints used in real patient plan because of many constraints to be included in summary in the table. We delivered five pcsr verification plans on a daily basis over a period of research and tracked them to assess their usefulness. Several real patients under treatments (Table 2) were also tracked to test the usefulness of this pcsr QA through comparisons between them.

Fig. 4

Pcsr QA plans. (A–E) Represent pcsr plans for five treatment sites: Brain, Head & neck, chest, abdomen, and pelvis, respectively. The left, middle, and right column show the contours in real plan, those mapped onto pcsr phantom CT, and isodose distribution on pcsr CT, respectively.

Brief Information on 5 Plan-class Specific VMAT Plans

Brief Information on 12 Real Patient Plans

Results and Discussion

We first investigated how much MLC movement and dosimetric error occurs in regular delivery of pcsr plans and additionally tried to compare with those occurred in regular delivery of real VMAT plans. The basic performance of pcsr plans were evaluated with MLC movement and gamma index analyses.

1. MLC movement analysis

MLC movement error is considered as one of key causes of dose distribution error. We evaluated it from data in Dynalog file. Dynalog file contains MLC position information of each 0.05 second interval of any radiotherapy session. It is created with the MLC controller of medical LINACs from Varian (Varian Medical Systems, Palo Alto, CA, USA). We first analyzed dynalog file data with Dynalog File Viewer (DFV) (version 7, Varian Medical Systems). DFV [9] is a useful utility program, installed in Four Dimensional Integrated Treatment Console (4DITC), the computer console of the LINAC. However, DFV only show MLC position error, it does not show us anything about leaf speed error. Also, DFV does not show how much MLC movement errors occurred in different positions of irradiated treatment field. Therefore, we used MATLAB program for more detailed analysis of position and speed of individual MLC leaf.

The MATLAB program anticipated all MLC position data in dynalog files of all plans. Then leaf positions were magnified with the magnification factor 1.966; dynalog file contains leaf positions at their physical plane [9] but we needed to evaluate all leaf positions on the horizontal plane through isocenter. The used magnification factor was the ratio between source to MLC bottom distance and MLC bottom to isocenter distance, calculated from the data in DICOM RTPLAN file. Equation 1 and 2 was used to calculate MLC speed and error, respectively. N in these equations stands for leaf position tag at 0.05 seconds time of the VMAT session. MLC controller of pre-TrueBeam LINACs from Varian (Varian Medical Systems) records MLC position information at 0.05 seconds interval of beam delivery.

(1) SpeedN=(PositionN-PositionN-1)/0.05
(2) ErrorN=ActualvalueN-PlannedvalueN

1) MLC positional error

We evaluated daily MLC position error occurred in delivering pcsr verification plan and real treatment plans. Maximum of Root Mean Square (maxRMS) of MLC position among all active leaves was evaluated with DFV and MATLAB program.

(1) MLC position error analysis with DFV

DFV provides a simple and useful evaluation tool of MLC performance with the recommended tolerance <0.35 cm for maxRMS of MLC position error [13]. Figure 5 shows the daily distributions of the maxRMS by DFV for 5 different pcsr QA plans and 12 real treatment plans which were grouped into the corresponding plan class. Similar MLC position error was revealed by different other previous works [1013]. The maxRMSs for all plans were all within the tolerance limit. The maxRMSs of real plans were compared with those of their pcsr plan and resulted in good acceptable fluctuation range in reference to their pcsr plans (Figure 6). These results can, carefully but not definitely, lead to guess that the simple DFV analysis of the maxRMSs with pcsr QAs could be a simple and useful tool to check the MLC performance of real VMAT plans belonging to their plan class.

Fig. 5

Daily distribution of maxRMS of MLC position error evaluated with DVF for pcsr and real treatment plans which were categorized into their pcsr class. (A–E) Represent the parameter for brain, head & neck, chest, abdomen, and pelvis class VMAT plans. The maxRMSs show good agreement with the tolerance of 0.35 cm.

Fig. 6

Tracking the position of maximum position error (maxPE) of the leaf number with the biggest maxRMS of position error among all leaf numbers. (A–E) Represent the parameter for brain, head & neck, chest, abdomen, and pelvis class VMAT plans. These tracking can be useful to check the quality of repeatability of MLC movement for VMAT delivery.

(2) MLC position error analysis with MATLAB

DVF allows users a simple and easy access to the information of maxRMS of MLC position error for individual leaf in bank A and B. However, you cannot get the positional information from DVF of where the maxRMS occurs in the total range of individual leaf moving. Neither any recommended parameter in guidelines [14] nor any commercial software of dynalog file analysis help us to know which portion of the irradiated area is affected by big MLC position errors. We used MATLAB from Dynalog file to catch where the maximum position error (maxPE) of individual leaf occurs in travelling each 1 mm path inside the irradiated area. We tracked only the specific leaf number with the biggest maxRMS of position error among all leaves.

The maxRMS of position error is useful to evaluate the temporary performance of MLC movement whereas positional constancy or variation of maxPE can be a good indicator of the stability and repeatability of MLC movement during VMAT delivery session. Figure 6 shows the daily distribution of the position of maxPE of the leaf number with the biggest maxRMS of position error among all leaf numbers for 5 different plan class. The positional variation of maxPEs for both pcsr and real plans were observed very stable (≤±8.6× 10−4%) over the research session, which argues the good stability and repeatability of MLC movement during VMAT delivery session. Moreover, the real plans in their plan class showed similar variation as their pcsr plan (Figure 6), which could lead to meaningful correlation that pcsr QA plans can be a good guideline to check mid-term quality of MLC movement for real VMAT delivery.

2) MLC Speed error

In this work, we also tried to analyze MLC speed properties because it is an important VMAT plan parameter and it has direct relation to beam to the scale of beam modulation and deliverability [6, 1417, 28]. Thus, VMAT plans can be characterized by MLC speed. DFV is a handy tool to analyze MLC position accuracy and beam held status, but it cannot provide us MLC speed information. We focused in this research on the daily variation of maxRMS of speed error over the research period because it can be another evidence on a good mid-term quality of VMAT treatment deliveries. We used the MATLAB program from dynalog files to calculate maxRMS of MLC speed error for daily QA sessions of five pcsr QA plans and real treatment plans. Figure 7 shows the calculated daily maxRMSs of MLC speed error for five different plan class, treatment sites, that is to say, brain, head & neck, chest, abdomen, and pelvis plan class. We found similar trend of speed error as Litzenberg et al. [20] shown in their software demonstration.

Fig. 7

Daily variation of maxRMS of MLC speed for pcsr and real treatment plans which were categorized into their pcsr class. (A–E) Represent the parameter for brain, head & neck, chest, abdomen, and pelvis class VMAT plans. Variation was highly stable over the research period, which implied the good mid-term quality of VMAT treatment deliveries.

Daily variations for real VMAT plans in Figure 7 were observed very comparable to those in their pcsr plans. The analogy with their figure could lead to careful but significant inference that pcsr QA plan could be a surrogate for the QA of real VMAT plan over a treatment session. The difference of maxRMSs of speed error between real plans and their pcsr plan in Figure 7 doesn’t let us come to an easy conclusion that pcsr have significant relation with real plans as their surrogate, different than position error analysis. It comes from the limit of pcsr plan, which was simply created from selecting randomly one of real plans in plan class. The simple classification of plans by treatment sites results in different modulation levels among plans even in the same plan class. It will be best to categorize plans by their modulation level to create plan class. However, we didn’t do it in this work and leave it behind as future work. In spite of such limitation, Figure 7 argues that pcsr plan can play a good role of predicting mid-term quality of real VMAT plans over the treatment session even for one time plan QA.

2. Dosimetric analysis

The final accuracy of beam delivering should be evaluated in terms of delivered radiation dose. Gamma pass rate has been commonly used to evaluate the dosimetric accuracy of beam delivering [21]. We used the Portal dosimetry system using electronic portal imaging devices (version aS1000, Varian Medical Systems) to analyze gamma pass rate with the criteria of pass rate 95% for 3%-3 mm, which is commonly used criteria for pass rate in clinical practice, and added the 2%-2 mm criteria. We evaluated planar dose distribution in the area encompassed by completely irradiated area outline (CIAO) +10 mm margin. Improved gamma algorithm option was used for global gamma analysis, when normalization mode was set to absolute, and local gamma threshold was set to 20%. Portal Dosimetry Reference Guide [22] for using the portal dosimetry module in Eclipse (Version 11, Varian Medical Systems) details these tools.

In this work, we hoped to predict the mid-term quality of real VMAT deliveries using pcsr QA plans and paid attention to the daily variation of gamma pass rate rather than its value. Figure 8 shows how gamma pass rates of both pcsr QA plan and treatment plans in their plan class varied on a daily basis over this study period. Similar gamma pass rate was observed in other earlier studies [6, 2325]. It was observed that the daily variation of both pcsr plans and real plans in their plan class had a similar trend for the criteria of both 3%-3 mm and 2%-2 mm. These findings enable us to infer that pcsr QA plan could be a good surrogate for real VMAT plan to predict the mid-term stability and repeatability of real plan without its daily plan QA. The gamma analysis performed in this study can be supplemented by organ based gamma index like that suggested in AAPM TG 218 [26]. However, it is beyond this research scope and left behind for future work.

Fig. 8

Daily gamma analysis with 3%-3 mm (left) and 2%-2 mm (right) gamma criteria. (A–E) Represent the daily variation of gamma pass rate for brain, head & neck, chest, abdomen, and pelvis class VMAT plans. Gamma pass rate of only first arc of two arcs are shown.

Advanced radiotherapy technologies like VMAT demands dosimetric accuracy as well as mechanical accuracy. The present guidelines for LINAC QA are not updated as fast as new technologies come to the market. For example, present guidelines [14] recommend monthly PF test for MLC QA, but researches [27, 28] found that we need daily MLC QA. More importantly, the MLC movement error revealed in this strenuous test cannot represent the MLC movement error occurred in real treatment delivery [14]. AAPM TG 100 [29] clearly addressed this issue in their 153rd failure mode error analysis (FMEA). Some radiotherapy centers perform periodic “Class-solution QA” [30] to guarantee that the basic dosimetry remains valid. Our proposed pcsr QA can be good alternative, because it includes both of mechanical and dosimetric QA of the LINAC. Ours is an elementary proposal and further work can be done to enhance plan class or to include 3D dosimetric evaluation in pcsr QA.

CONCLUSION

In this work we partitioned human body into five different anatomical sites, that is, five plan class and made a new proposal of pcsr plan to represent each class as a part of regular LINAC QA for VMAT plan. Of course, this newly proposed pcsr plan leaves much to be desired so it needs additional future research. In spite of its shortcomings, we believe that the pcsr QA proposed in this study would be useful and helpful to predict the mid-term (~roughly one month or less) quality of real VMAT treatment delivery.

ACKNOWLEDGEMENT

This work was supported by the Nuclear Safety Research Program through the Korea Foundation Of Nuclear Safety (KoFONS) using the financial resource granted by the Nuclear Safety and Security Commission (NSSC) of the Republic of Korea (No. 1705006).

References

1. Eric EK, et al. Task Group 142 report: Quality assurance of medical accelerators. Med Phys 2009;36(9):4197–4212.
2. Choi SH, Park D, Kim KB, Kim DW, Lee J, Shin DO. Suggestion for comprehensive quality assurance of medical linear accelerator in Korea. Prog Med Phys 2015;26(4):294–303.
3. Smith K, Balter P, Duhon J, White GA Jr, Vassy DL Jr, Miller RA, Serago CF, Fairobent LA. AAPM Medical Physics Practice Guideline 8.a.: Linear accelerator performance tests. J Appl Clin Med Phys 2017;18(4):23–39.
4. Nederlandse Commisssie Voor Stralingsdosimetrie. Code of Practice for the Quality Assurance and Control for Volumetric Modulated Arc Therapy. Report 24 of the Netherlands Commission on Radiation Dosimetry 2015. p. 9–59.
5. Ezzell GA, et al. IMRT commissioning: Multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys 2009;36(11):5359–5373.
6. Rahman MM, Kim CH, Kim S. Daily based quality assurance of volumetric modulated arc therapy for the full session of treatment. J Korean Phys Soc 2018;73(7):990–1000.
7. Choi SH, Jeong JH, Cho S, Chung MS, Huh HD, Kim WC, Cho KW, Kim CH. Construction of a High-quality Voxel Model VKH-Man Using Serially Sectioned Images from Visible Korean Human Project in Korea. J NUCL SCI TECHNOL 2008;Suppl 5. :179–182.
8. Kim CH, Jeong HJ, Bloch WE, Cho KW, Hwang SB. A polygon-surface reference Korean male phantom (PSRK-Man) and its direct implementation in Geant4 Monte Carlo simulation. Phys Med Biol 2011;56:3137–3161.
9. Dynalog File Viewer Reference Guide (P/N 100013698-05) Varian Medical Systems. Palo Alto. CA USA: January. 2011.
10. McGarry CK, Agnew CE, Hussein M, Tsang Y, Hounsell AR, Clark CH. The use of log file analysis within VMAT audits. Br J Radiol 2016;89:20150489.
11. Kosaka K, Tanooka M, Doi H, Inoue H, Tarutani K, Suzuki H, Takada Y, Fujiwara M, Kamikonya N, Hirota S. Feasibility of estimating patient-specific dose verification results directly from linear accelerator log files in volumetric modulated arc therapy. Int J Medical Physics, Clinical Engineering and Radiation Oncology 2016;5:317–328.
12. Kim JI, Choi CH, Wu HG, Kim JH, Kim K, Park JM. Correlation analysis between 2D and quasi-3D gamma evaluations for both intensity-modulated radiation therapy and volumetric modulated arc therapy. Oncotarget 2017;8:5449–5459.
13. Defoor DL, Quino LAV, Mavroidis P, Papanikolaou N, Stathakis S. Anatomy-based, patient-specific VMAT QA using EPID or MLC log files. J Appl Clin Med Phys 2015;16(3):206–215.
14. Kerns JR, Childress N, Kry SF. A multi-institution evaluation of MLC log files and performance in IMRT delivery. Radiat Oncol 2014;9:176.
15. Scaggion A, Negri A, Rossato MA, Roggio A, Simonato F, Bacco S, Paiusco M. Delivering RapidArc®: A comprehensive study on accuracy and long term stability. Phys Medica 2016;32:866–873.
16. Park JM, Wu HG, Kim JH, Carlson JNK, Kim K. The effect of MLC speed and acceleration on the plan delivery accuracy of VMAT. Br J Radiol 2015;88:20140698.
17. Alonso JO, Galiñanes AV, Pellejero SP, Azorín JFP. Evaluation of MLC performance in VMAT and dynamic IMRT by log file Analysis. Physica Medica 2017;33:87–94.
18. Venencia CD, Besa P. Commissioning and quality assurance for intensitymodulated radiotherapy with dynamic multileaf collimator: Experience of the Pontificia Universidad Católica de Chile. J Appl Clin Med Phys 2004;5(3):37–54.
19. Chui CS, Spirou S, LoSasso T. Testing of dynamic multileaf collimation. Med Phys 1996;23(5):635–641.
20. Litzenberg DW, Moran JM, Fraass BA. Verification of dynamic and segmental IMRT delivery by dynamic log file analysis. J Appl Clin Med Phys 2002;3(2):63–72.
21. Nelms BE, Simon JA. A survey on planar IMRT QA analysis. J Appl Clin Med Phys 2007;8(3):76–90.
22. Portal Dosimetry Reference Guide (P1015288-001-A) Varian Medical Systems. Palo Alto. CA USA: 2015.
23. Jin J, Jesseph FB, Ahmad S. A comparison study of volumetric modulated arc therapy quality assurances using portal dosimetry and MapCHECK 2. Prog Med Phys 2014;24:65–71.
24. Hussein M, Rowshanfarzad P, Ebert MA, Nisbet A, Clark CH. A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems. Radiat Oncol 2013;109:370–376.
25. Woon WA, Ravindran PB, Ekayanake P, Vikraman S, Lim YYF, Khalid J. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA. J Appl Clin Med Phys 2018;19(2):230–248.
26. Miften M, et al. Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218. Med Phys 2018;45(4):e53–e83.
27. Agnew A, Agnew CE, Grattan MWD, Hounsell AR, McGarry CK. Monitoring daily MLC positional errors using trajectory log files and EPID measurements for IMRT and VMAT deliveries. Phys Med Biol 2014;59:N49.
28. LoSasso T. IMRT Delivery Performance with a Varian Multileaf Collimator. Int J Radiation Oncology Biol Phys 2008;71:S85.
29. Huq MS, et al. The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management. Med Phys 2016;43(7):4209–4262.
30. Bortfeld T, Ullrich RS, Neve WD, Wazer DE, eds. Image-Guided IMRT Verlag Berlin Heidelberg: Springer; 2006. p. 117–128.

Article information Continued

Fig. 1

Classification of plans by treatment sites. The whole body is divided into five anatomical divisions and the plan-class specific QA plans for each section are created.

Fig. 2

The computational human phantom developed in Hanyang University Radiation Engineering Laboratory (HUREL) with name of HDRK-Man. It includes 30 organs. For more information visit http://hurel.hanyang.ac.kr.

Fig. 3

Mapping of contours in real patient CT into a pcsr phantom. (A) In the picture shows a real patient CT image and its contours of organs at risk and (B) shows phantom CT image and mapped contours. Mapped contours were so trimmed through manual smoothing that they imitate as close to original ones as possible.

Fig. 4

Pcsr QA plans. (A–E) Represent pcsr plans for five treatment sites: Brain, Head & neck, chest, abdomen, and pelvis, respectively. The left, middle, and right column show the contours in real plan, those mapped onto pcsr phantom CT, and isodose distribution on pcsr CT, respectively.

Fig. 5

Daily distribution of maxRMS of MLC position error evaluated with DVF for pcsr and real treatment plans which were categorized into their pcsr class. (A–E) Represent the parameter for brain, head & neck, chest, abdomen, and pelvis class VMAT plans. The maxRMSs show good agreement with the tolerance of 0.35 cm.

Fig. 6

Tracking the position of maximum position error (maxPE) of the leaf number with the biggest maxRMS of position error among all leaf numbers. (A–E) Represent the parameter for brain, head & neck, chest, abdomen, and pelvis class VMAT plans. These tracking can be useful to check the quality of repeatability of MLC movement for VMAT delivery.

Fig. 7

Daily variation of maxRMS of MLC speed for pcsr and real treatment plans which were categorized into their pcsr class. (A–E) Represent the parameter for brain, head & neck, chest, abdomen, and pelvis class VMAT plans. Variation was highly stable over the research period, which implied the good mid-term quality of VMAT treatment deliveries.

Fig. 8

Daily gamma analysis with 3%-3 mm (left) and 2%-2 mm (right) gamma criteria. (A–E) Represent the daily variation of gamma pass rate for brain, head & neck, chest, abdomen, and pelvis class VMAT plans. Gamma pass rate of only first arc of two arcs are shown.

Table 1

Brief Information on 5 Plan-class Specific VMAT Plans

Treatment sites Brain Head & Neck Chest Abdomen Pelvis
Diagnosis* Meningioma Tongue Lung Liver Prostate
Nominal Energy (MV) 6 6 6 6 10
Number of arcs 2 2 2 2 2
Arc Angle (degree) 181–179 181–179 350–179 181–50 250–110
Dose per fraction (cGy) 200 225 220 200 200
Number of Fraction 10 10 10 10 10
*

Diagnosis came from original patient plan.

First angle says start angle and second one represents stop angle.

Represents the total number of delivered pcsr plans over this research period.

Table 2

Brief Information on 12 Real Patient Plans

Plan class Real plan Fraction Daily dose (cGy) Number of arcs Arc angle (Deg)
Brain Meningioma 10 200 2 181–179

Head & Neck Nasal cavity 10 200 2 240–120
Pharynx 10 200 2 200–60
Tonsil 10 225 2 181–179
Parotid 10 225 2 0–179
Larynx 10 200 2 181–179
Nasopharynx 10 225 2 181–179

Chest Lung 10 200 2 350–179
Breast 10 210 2 350–179

Abdomen Liver 10 200 2 181–50
Pancreas 10 200 2 290–70

Pelvis Prostate 10 200 2 250–110